SciELO - Scientific Electronic Library Online

 
vol.12 número8Mamografía en el diagnóstico precoz de cáncer de mama en mujeres de 40-49 años con riesgo medio de padecer la enfermedadReacciones adversas neurológicas asociadas a ciprofloxacino índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Medifam

versão impressa ISSN 1131-5768

Resumo

SANCHEZ LITE, I.; CAL DE LA FUENTE, A. de la; FRUTOS LLANES, R.  e  CANO DEL POZO, M.. Are we aware of the side effects of the drugs we prescribe? . Medifam [online]. 2002, vol.12, n.8, pp.75-78. ISSN 1131-5768.

Many of the medicines used daily and which are supposed harmless, may in fact produce numerous side-effects which can, on occasions, be life-threatening. Agranulocytosis is an uncommon alteration of the blood consisting of severe neutropenia with serious associated infections and a high mortality rate. A great number of medications have been associated with the production of agranulocytosis: antibiotics, anti-inflammatory, anti-depressants, etc. Of these medicines metamizol has been one of the most closely-associated with this blood disorder. Widely used, metamizol, is very popular not only in medical circles, but also amongst patients who are able to buy it without prescription from any pharmacy in our country. Although the association between agranulocytosis and metamizol is not common, we should be aware of the grave consequences which may arise. This was the case of the patient described who, having taken metamizol, required urgent treatment at home, before being admitted to hospital. Emergency room analysis revealed agranulocitosis. The patient was admitted to the Intensive Care Unit where, in spite of support and anti-biotherapy, she died within a few hours. 

Palavras-chave : Agranulocytosis; Anti-inflammatory agents; Non-steroidal; Dipyrone; Neutropenia; Side Effects; Mortality.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons